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Abstract
The antioxidant vitamin E is a commonly used vitamin supplement. Al-
though the multi-billion dollar vitamin and nutritional supplement indus-
try encourages the use of vitamin E, there is very little evidence support-
ing its actual health benefits. Moreover, vitamin E is now marketed as a
lipid raft destabilizing anti-cancer agent, in addition to its antioxidant be-
haviour. Here, we studied the influence of vitamin E and some of its vitamers
on membrane raft stability using phase separating unilamellar lipid vesicles
with small angle scattering techniques and fluorescence microscopy. We find
that lipid phase behaviour remains unperturbed well beyond physiological
concentrations of vitamin E (up to a mole fraction of 0.10). Our results
Preprint submitted to Biochimica et Biophysica Acta January 7, 2020
are consistent with a proposed line active role of vitamin E at the domain
boundary. We discuss the implications of these findings as they pertain to
lipid raft modification in native membranes, and propose a new hypothesis
for the antioxidant mechanism of vitamin E.
Keywords: Vitamin E, α-tocopherol, γ-tocopherol, Lipid rafts, Small-angle
neutron scattering, Lipid bilayer
1. Introduction1
Vitamin E was discovered in 1922 by Evans and Bishop as a vital dietary2
biomolecule for mammalian reproduction. Yet, to this day its precise biolog-3
ical role continues to be debated [2, 3, 4]. Vitamin E refers to two families4
of molecules known as tocopherols and tocotrienols, each comprised of four5
members (α, β, γ, and δ) differing in methylation of their chromanol ring (see6
Figure 1). Considering this somewhat minor structural difference between7
family members, and the fact that all species are regularly consumed in the8
average diet, it is remarkable that α-tocopherol is the only one of the eight9
variants actively retained by the human body [5, 6].10
A large body of literature advocates that vitamin E is the first line of11
defense for cell membranes against oxidation [8, 9]. As a result, vitamin E12
is commonly used as a bio-compatible preservative in the cosmetic and food13
industries [7]. However, and to the best of our knowledge, the role of vitamin14
E in vivo remains ambiguous. Some studies allude to a role in homeostatic15
processes, and deficiency of vitamin E leads to diseases such as infertility and16
neuromuscular dysfunction, all without elucidated mechanisms [1, 10]. The17
lack of good experimental evidence and the fact that vitamin E is found in18
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α-tocopherol (αToc) CH3 CH3 
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Figure 1: Structures of the tocopherol members of the vitamin E family. Here we examine:
α-tocopherol (αToc) the species preferentially taken-up by the human body; γ-tocopherol
(γToc) the most naturally abundant species [7]; and the stable oxidation product of αToc,
α-tocopherylquinone (αTocQ).
extremely low concentrations in vivo [11], calls into question its antioxidant-19
centric role [4].20
It is not surprising that vitamin E properties are propagated by industry21
and health professionals that advocate for the sale of dietary supplements.22
Across North America, an estimated sixty percent of middle-to-late-aged23
adults consume vitamins, including vitamin E, while sufficient recommended24
amounts can generally be obtained from a balanced diet [12]. Nutrition25
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companies offer a variety of vitamin E supplements ranging from pure RRR-26
α-tocopherol to “natural” mixtures containing all of the tocopherol family27
members, often in amounts ranging from 3 to 30 times the recommended28
daily intake [7]. While the health benefits of sufficient dietary antioxidants29
are well documented, vitamin E is also marketed for promoting cardiovascular30
health and as an anti-cancer agent [13, 14].31
The rationale for vitamin E as an anti-cancer agent is predicated on a32
proposed mechanism of membrane raft destabilization [15]. Cell membranes33
have been implicated in a vast array of cellular processes, which can often34
be facilitated by the lateral organization of lipids and proteins into micro35
and nanoscale “rafts” [16, 17]. It is thought that certain varieties of cancer36
cells, particularly prostate and breast, possess more robust lipid rafts that37
can be destabilized through cholesterol depletion by raft-modulating agents38
such as methyl-β-cyclodextrin [18, 15, 19]. This hypothesis has thus inspired39
many studies investigating the potential anti-cancer effects of vitamin E.40
Notably, Yang et al. have suggested that high-dose supplementation of γ- and41
δ- tocopherols inhibits tumorigenesis, while α-tocopherol does not [20, 21, 22].42
Conversely, clinical trials involving α-tocopherol supplementation indicate an43
increased risk for developing prostate cancer in healthy men [14, 13].44
Observations of membrane rafts have been elusive in live cells, presumably45
due to their proposed small size and transient nature, in addition to the46
inherent complexity of biological membranes [23, 24]. More recently, lipid47
domains on the order of 40 nm in size were observed in living bacteria [25].48
Three-component lipid mixtures mimicking the outer leaflet of eukaryotic49
plasma membranes are commonly used as model systems for the study of50
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lipid rafts [26, 27]. Specifically, vesicles composed of high- and low-melting51
lipids, and cholesterol are thermodynamically unstable and demix into a52
cholesterol-rich liquid ordered (Lo) phase that coexists with a cholesterol-53
poor liquid disordered (Ld) phase. These structures are compatible for study54
by a range of biophysical techniques, including small-angle neutron and X-ray55
scattering [28], and fluorescence microscopy [29, 30, 31].56
In the current study we looked at how vitamin E affects lipid membranes,57
and if its behaviour is consistent with raft-disrupting anti-cancer mechanisms,58
in the hope of gaining a better understanding of vitamin E supplementation.59
2. Materials and Methods60
2.1. Materials61
1,2-dipalmitoyl-sn-glycero- 3-phosphocholine (16:0/16:0 PC, DPPC), 1,2-62
dipalmitoyl-d62-sn-glycero-3-phosphocholine (16:0[d31]/16:0[d31] PC, d62-63
DPPC), 1,2-dioleoyl-sn-glycero-3-phosphocholine (18:1/18:1 PC, DOPC), and64
1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B65
sulfonyl) (LR-DPPE) were purchased from Avanti Polar Lipids, Inc. (Al-66
abaster, AL). Cholesterol, DL-all-rac-α-tocopherol (α-tocopherol, αToc), (R,R,R)-67
γ-tocopherol (γ-tocopherol, γToc), D-α-tocopherylquinone (α-tocopherylquinone,68
αTocQ), and sucrose were purchased from Sigma-Aldrich (St. Louis, MO).69
Naphtho-[2,3-a]pyrene (naphthopyrene) was purchased from TCI America70
(Tokyo, Japan). 99.9 % D2O was purchased from Cambridge Isotopes (An-71
dover, MA). All reagents were used without further purification.72
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2.2. SANS Sample Preparation73
2.2.1. Selection of Lipid Composition74
All experiments were performed using a mixture of DPPC/DOPC/Chol75
at a mole ratio of 37.5/37.5/25, respectively. This composition contains a76
1:1 ratio of high- and low-melting lipids such that the area fractions of Lo77
phase and Ld phase domains are approximately equal. The phase behaviour78
of this composition has carefully been characterized by different techniques79
in a number of previous studies, thereby offering a reliable foundation for80
this work [30, 32, 33].81
2.2.2. Preparation of Unilamellar Vesicles82
Well-established protocols were followed to prepare unilamellar vesicles83
(ULVs) for scattering measurements. In brief, lipid mixtures were prepared84
by transferring desired volumes of stock solutions in HPLC-grade chloro-85
form to a scintillation vial using a glass syringe (Hamilton USA, Reno, NV).86
Lipid films were formed through chloroform evaporation under a gentle argon87
stream, followed by trace solvent removal in vacuo for >12 hours. The films88
were hydrated to 20 mg/ml by the addition of a 34.6% D2O/H2O mixture,89
and incubated for 30 minutes at 50 ◦C prior to the formation of a multilamel-90
lar vesicle (MLV) suspension by vortexing. The ratio of D2O/H2O was used91
to replicate the contrast matching scheme described by Heberle et al., such92
that the scattering length density of the aqueous solvent is simultaneously93
matched to the that of the lipid headgroup and average hydrocarbon chain94
compositions. This contrast matching scheme minimizes scattering contri-95
butions arising from transverse (i.e., normal to the plane of the bilayer)96
scattering length density variation, and emphasizes scattering contributions97
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arising from in-plane heterogeneity (i.e., demixing of saturated and unsat-98
urated chains) [34]. The MLV suspension was subjected to 5 freeze/thaw99
cycles between -80 ◦C and 50 ◦C, followed by vortexing at 50 ◦C. ULVs were100
then prepared by 31 passes through a hand-held miniextruder equipped with101
a 50 nm pore-diameter polycarbonate filter (Avanti Polar Lipids, Alabaster,102
AL) and heated to 50 ◦C. Extruded vesicles were characterized by dynamic103
light scattering on a Malvern ZetaSizer Nano ZS (Malvern Panalytical, Ltd.,104
Malvern, UK).105
2.3. Characterization of Phase Separation by Contrast-Matched SANS106
Neutron scattering experiments were performed at the Very Small-Angle107
Neutron Scattering (NG3-VSANS) instrument located at the National Insti-108
tute of Standards and Technology Center for Neutron Research (NIST-CNR).109
The white beam option was configured to use a neutron wavelength of 5.3110
Å with a ∆λ/λ of 40%. Data were collected using two detector carriages111
positioned at sample-to-detector distances of 5.4 m and 13 m. This single112
configuration and large wavelength spread results in lower q-resolution, but113
allows for higher flux at the point of the sample, and thus shorter count114
times. In this case, good quality data in a scattering vector range of 0.009115
Å−1 < q < 0.5 Å−1 were acquired in three minutes.116
Additional experiments were performed at the CG-3 Bio-SANS instru-117
ment of the High Flux Isotope Reactor (HFIR) located at Oak Ridge Na-118
tional Laboratory (ORNL). Data were taken at a sample-to-detector distance119
of 15.5 m using 6 Å wavelength neutrons (fwhm 15%). A total scattering120
vector of 0.003 Å−1 < q < 0.8 Å−1 was collected using a two-dimensional121
(1 m × 1 m) 3He position-sensitive detector (ORDELA, Inc., Oak Ridge,122
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TN) with 192 × 256 pixels in combination with a 1 m × 0.8 m wing detector123
comprised of 160 × 256 pixels and rotated by 1.40◦.124
ULV suspensions of 20 mg/ml were loaded into 1 mm path-length banjo125
cells (Hellma USA, Plainview, NY) and mounted in a Peltier temperature-126
controlled cell holder with ≈1 ◦C accuracy. Samples were measured at 7 tem-127
peratures, ranging from the two-phase (Lo / Ld) liquid coexistance regime at128
lower temperatures through to the uniformly melted Ld phase at higher tem-129
peratures. At a minimum, samples were permitted to equilibrate at each tem-130
perature for 20 minutes prior to measurement. Data were reduced, stitched,131
and corrected for detector pixel sensitivity, dark current, sample transmis-132
sion, and background scattering from water using ORNL’s Mantid software133
(BioSANS) [35] or the appropriate Igor Pro macros (VSANS) provided by134
NIST-CNR [36].135
The resulting data were analyzed in a model-independent manner using136





With the contrast matching scheme used here, Q to a first approximation138
is only dependent on the area fraction of the Lo phase (aLo) and the difference139
in contrast between the Lo and Ld domains (∆ρ) [38]:140
Q ≈ aLo(1− aLo)∆ρ2 (2)
Since neutron contrast depends on how strongly the deuterated and proti-141
ated lipids are segregated, SANS measurements can detect changes in domain142
area fraction (aLo) or a change in the partitioning of the lipids between the143
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coexisting phases. For example, either a decrease in domain area fraction,144
or reduced partitioning of saturated and unsaturated lipids between the two145
phases, will cause a decrease in the total scattering according to Eq. 2. Both146
of these features imply a destabilization of lipid domains.147
2.4. Bilayer Structure from SAXS148
Small angle X-ray scattering (SAXS) experiments were performed on the149
same samples measured by SANS. ULVs at a concentration of 10 mg/ml were150
measured using a Rigaku BioSAXS-2000 (Rigaku Americas, The Woodlands,151
TX) equipped with a Pilatus 100K detector and an HF007 rotating copper152
anode source. All samples were measured above the phase transition tem-153
perature (50 ◦C) to ensure well mixed bilayers. Multiple measurements were154
obtained for each sample, and samples were monitored for radiation damage155
before averaging. Resulting form factors in the scattering vector range of156
0.04 Å−1 < q < 0.6 Å−1 were background-corrected using PRIMUS [39] and157
modeled using the Global Analysis Program (GAP) developed by Pabst et al.158
[40, 41].159
2.5. Preparation and Fluorescence Imaging of Giant Unilamellar Vesicles160
Giant unilamellar vesicles (GUVs) suitable for epifluorescence microscopy161
were generated using a modified electroformation protocol as described by162
Konyakhina and Feigenson [42, 43]. In brief, lipid mixtures with and without163
a vitamin E mole fraction of 0.10 (χ = 0.10) were mixed in chloroform and164
combined with fluorescent probes at predefined mole ratios. The mixture165
was then spread evenly onto a conductive indium tin oxide (ITO)-coated166
slide (Delta Technologies, LTD., Loveland, CO). The fluorescent probes167
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(χLR−DPPE = 0.005 and χnaphthopyrene = 0.01) were chosen based on their168
known lipid phase partitioning behavior [44]. Solvent was removed by overnight169
drying in vacuo for >12 hours. GUVs were then formed in 100 mmol/L170
aqueous sucrose by heating for 1 h at 50 ◦C with electroformation by a 10171
Hz sinusoidal current with a peak-to-peak amplitude of 1 V. The samples172
were gradually cooled to room temperature over 10 h using a Digi-Sense173
benchtop temperature controller (Cole Parmer, Vernon Hills, IL) to mini-174
mize kinetically-trapped domain artifacts. GUVs were transferred to a glass175
coverslip enclosed by a silicon gasket, sealed by a glass slide, and allowed to176
settle for 1 h prior to imaging. All samples were imaged at ambient tempera-177
ture within 24 h of preparation using an inverted epifluorescence microscope178
(Leica DMI6000, Wetzlar, Germany). LR-DPPE was detected using a Texas179
Red filter cube (ex. 594 nm / em. 598 nm) and naphthopyrene was detected180
using a DAPI filter cube (ex. 357 nm / em. 459 nm). Care was taken to181
prevent light-induced phase separation by minimizing illumination intensity182
and exposure [45, 46]. Resulting images were artificially recoloured for pub-183
lication using the Leica LAS X software to improve accessibility for readers184
with vision impairment.185
3. Results and Discussion186
3.1. Tocopherol does not affect bilayer structure187
Phase separating ULVs suspended in water were heated to 50 ◦C to en-188
sure a uniform distribution of the lipids, thus ensuring a bilayer of uniform189
thickness suitable for structural studies by SAXS. To quantify any differences190
in bilayer structure, the scattering form factors were modeled using the GAP191
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program to determine physical parameters [40, 41]. GAP models an electron192
density profile of the bilayer by parameterizing three Gaussians, one for each193
electron-rich head group and one for the hydrocarbon region. As X-rays are194
sensitive to the electron-rich phosphates in the lipid head groups, we report195
the headgroup-headgroup distance of the bilayers (dHH) from the optimized196
modelled form factor. Note, dHH is directly determined and requires no sub-197
sequent calculations or assumptions about the system. As explained in the198
SI, due to the complexity of the multi-component systems, some parameters199
were fixed to refine the fit.200
Table 1 summarizes dHH for each composition explored and additional fit201
parameters are shown in Table S1 of the Supplementary Material. Mea-202
sured headgroup-headgroup distances for DPPC/DOPC/Chol are consis-203
tently within 2% of previously reported values [33, 47, 48]. Interestingly,204
up to a mole fraction of 10% tocopherol, the transverse bilayer structure is205
not significantly perturbed. The slight thinning of the bilayer upon addi-206
tion of tocopherol is likely an artifact of fixing the width of the Gaussian207
describing the headgroup, σH. Due to the orientation of tocopherol in the208
membrane, with its chromanol headgroup residing at the hydrophilic inter-209
face [49, 50, 51], additional electron density will be present slightly inside the210
headgroup Gaussian, which is best described by a wider σH and an asym-211
metric Gaussian. Since the GAP program cannot parameterize for skewed212
Gaussians, it compensates for this distribution by shifting the position of the213
headgroup, zH, closer to the bilayer center. This trend is most dramatic for214
αTocQ, though only 1.4 Å thinner, where the electron-rich benzoquinone215
head contributes to a greater proportion of the electron density within the216
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bilayer, just beyond the phosphate group. Indirectly, this suggests that both217
γToc and αTocQ are likely to localize in the membrane similarly to αToc,218
consistent with past neutron diffraction observations [51].219
Table 1: Bilayer thickness, represented by the headgroup-headgroup distance, DHH , as a
function of percent tocopherol. Parameters were derived from modelling small angle X-ray
scattering data, with uncertainties defined as 2%
Composition DHH (Å)
DPPC/DOPC/Chol 39.9 ± 0.8
+ 2 % αToc 39.2 ± 0.8
+ 5 % αToc 39.2 ± 0.8
+ 2 % γToc 39.7 ± 0.8
+ 10 % γToc 39.2 ± 0.8
+ 2 % αTocQ 39.1 ± 0.8
+ 10 % αTocQ 38.5 ± 0.8
The following parameters were fixed based on physical considerations as described in
the SI [47]: width of Gaussian describing the phosphatidylcholine headgroup, σH =
3.0 Å, and amplitude of the Gaussian describing the hydrocarbon tail, relative to that
of the headgroup, ρC = -1.0. All fit parameters are tabulated in Table S1.
3.2. Tocopherol destabilises microscopic phase separation220
GUVs are widely used as models for probing the existence and mor-221
phology of phase separation at the microscopic level. In this study, the222
DPPC/DOPC/Chol 37.5/37.5/25 system displays robust hemispherical do-223
mains that can be visualized by the selective partitioning of naphthopyrene224
and LR-DPPE into the Lo and Ld membrane environments, respectively (Fig.225
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2A) [44]. At ambient temperature, the addition of χ = 0.10 α- (Fig. 2B) or226
γ- tocopherol (Fig. 2C) appears to abolish the phase separation, although227
the presence of domains smaller than the optical resolution limit (≈ 200 nm)228
cannot be ruled out. Similar suppression of phase separation is observed229
by heating the system to a point where the mixing entropy, which favours230
the random arrangement of lipids, dominates over the non-ideal enthalpic231
contribution to free energy, and results in increased acyl chain disorder and232
increased lateral lipid diffusion.233
In contrast to α- and γ-tocopherol, the presence of α-tocopherylquinone234
(αTocQ), even up to a mole fraction of 0.10, does not appear to change the235
phase behaviour (Fig.2D).236
3.3. Domain perturbations described by SANS237
Contrast-matched SANS is a powerful tool to probe the lateral orga-238
nization of lipids along the bilayer and from SANS one is able to extract239
precise structural features. An example of this is provided by the model-240
ing of SANS data to determine domain size in refs [34, 52]. According to241
the work of Pencer et al., due to the dependence of the scattering function242
on contrast, lateral segregation of deuterated and protiated lipids into do-243
mains yields a scattering contribution that directly correlates to the extent244
of phase separation. With this experimental design, data can be reduced to a245
model-independent scalar quantity known as the Porod invariant, Q (Eq. 2)246
representing the total scattering arising from system contrast [38]. Using this247
approach, phase behaviour can easily be obtained from the low q-resolution248
scattering of laterally heterogeneous vesicles. Using a DPPC/DOPC/Chol249
system, Figure 3(A) shows the difference in scattering obtained by varying250
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Figure 2: Fluorescence microscopy of GUVs composed of (A) DPPC/DOPC/Chol; (B) +
χ = 0.10 αToc; (C) + χ = 0.10 γToc and (D) + χ = 0.10 αTocQ. Naphthopyrene (blue)
preferentially localizes in the Lo phase and LR-DPPE (red) in the Ld phase. Subsequent
acquisitions of each fluorophore are colour-merged to highlight the different phases. Phase
separation is observed in the undoped system (A) and in the presence of αTocQ (D), but
is not observed with αToc (B) or γToc (C).
Temperature = 21 ◦C. Scale bar = 25 µm.
the q-resolution. High q-resolution data were collected at CG3-BioSANS251
(HFIR, ORNL) and low q-resolution data at NG3-VSANS (NCNR). By ex-252
tracting the Porod invariant and normalizing to a relative scale bound by the253
highest contrast (lowest temperature) and lowest contrast (highest tempera-254
ture), the temperature dependence of phase separation between samples can255
be directly compared (Fig. 3B). From this normalized scattering intensity,256
Qnorm, it can be shown that the decay in scattering intensity is not depen-257
dent on q-resolution. The low and high q-resolution data were obtained from258
different sample preparations of the same composition, and differences in259
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samples may account for the small variations in decay at 25 ◦C. The low q-260
resolution “white beam” of VSANS allows for rapid data collection resulting261
in high sample throughput. However, due to the large wavelength spread,262
∆λ
λ
, structural features are lost, as demonstrated by comparing Figure 3(A)263
and the inset to Figure 3(A). As a result, modeling the domain size in a fash-264
ion similar to Bolmatov et al. is not a viable approach [53]. Nevertheless,265
the use of the VSANS’ “white beam” option provides a 4x increase in flux266
over conventional SANS experiments and is particularly useful for measuring267
labile samples that may change during the data acquisition time required to268
collect good quality data on a conventional SANS instrument.269
Low q-resolution SANS curves featured in Figure 4 show a decrease in270
scattering intensity as a function of increasing temperature. Phase separa-271
tion in samples were confirmed to be thermodynamically stable and free of272
hysteresis effects by measuring sequential heating and cooling scans (Figure273
S2).274
The decrease in scattering intensity is a result of less contrast between the275
lipid phases as they become more miscible, induced by increasing temperature276
and the addition of tocopherol. Phase separation has been proposed to have277
biological implications, particularly at the level of protein regulation [54, 55].278
Though we must be cautious in extrapolating results from vesicle models279
to biology, this result may suggest that less distinction in the properties of280
the two phases may diminish the efficacy of segregating membrane proteins281
solely on the basis of phase preference.282
While valuable, the SANS form factors (Fig.4) do not offer a clear com-283
parison between the different lipid compositions. By reducing the data to284
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Figure 3: Comparison of different q-resolution SANS data. (A) Low resolution scattering
from DPPC/DOPC/Chol as a function of temperature from 15 ◦C (blue) to 45 ◦C (red).
The inset shows high q-resolution data from the same sample composition. A logarith-
mic scale is used to emphasize the difference between the form factors. (B) Normalized
scattering intensity (Q) as a function of temperature extracted from both the low- (black
circles) and high-resolution (grey squares). Error is defined as one standard deviation and
error bars are smaller than the data markers.
Q and normalizing each sample with the bounds of the DPPC/DOPC/Chol285
system in the absence of tocopherol, we are able to directly compare changes286
to the membrane by the presence of tocopherol. These trends are shown in287
Figure 5, which represents the structurally-independent total scattering from288
domains as a function of temperature. Remarkably, there is little apprecia-289
ble deviation in total scattering for samples containing χ = 0.02 or χ = 0.05290
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Figure 4: SANS intensity as a function of temperature and membrane composition. ULVs
of DPPC/DOPC/Chol and DPPC/DOPC/Chol +αToc, +γToc, and +αTocQ at a mole
fraction of 0.10 were measured at (15, 18, 25, 31, 34, 37, and 45) ◦C. The presence of
different tocopherols modulates both scattering intensity and the rate of intensity decay.
Plots show 0.009 Å−1 < q < 0.05 Å−1 to highlight the difference in scattering at low q.
αToc or γToc, however, domains appear to destabilize at higher (χ = 0.10)291
concentrations. Moreover, due to the strong similarity between the effects292
of αToc and γToc on phase behaviour, we suggest that this is likely not a293
determinant in biological selectivity for αToc.294
It is noteworthy that even at a high concentration, Q is not totally abol-295
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Figure 5: Normalized total scattering (Q) measured by low q-resolution SANS.
DPPC/DOPC/Chol samples containing χ = 0 (; black), χ = 0.02 (◦; green), χ =
0.05 (4; blue) and χ = 0.10 (♦, orange) of the vitamin E analogues αToc (top), γToc
(middle), and αTocQ (bottom). The mixtures were measured in the temperature range
of 15-45 ◦C. Smooth curves were added to assist in visualizing trends in the data. Error
is defined as one standard deviation and error bars are smaller than the data markers.
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ished, indicating that the membrane may not be homogeneous, but still con-296
tains nanoscale lateral heterogeneities. More likely, however, residual scat-297
tering intensity is a remnant of the inability to contrast match contributions298
from both lateral and transverse contrast simultaneously.299
There are many proposed mechanisms of nanodomain stabilization, in-300
cluding coupling of bilayer composition and curvature inducing a microemul-301
sion [56], line tension competing with a long range repulsive force [57], or302
Ising-like critical fluctuations [58]. Our data do not allow us to discriminate303
between these or other proposed theories of nanodomain stabilization. The304
most recently reported mechanism that has been suggested for vitamin E is305
that of a linactant-induced microemulsion [34, 59, 60, 61].306
Muddana et al. previously explored the phase activity of αToc using307
coarse-grained Molecular Dynamics simulations to complement GUV mi-308
croscopy observations [60]. Their results indicate αToc localizes to the do-309
main interface, thereby acting as a linactant to destabilize macrodomains.310
We must stress that with SANS we cannot comment on the localization of311
individual molecules, and though we cannot directly lend support to the312
mechanism proposed by Muddana et al., our results are qualitatively consis-313
tent. In fact, one cannot claim for certain a linactant mechanism without314
verifying that the molecule preferentially localizes to the phase boundary.315
Our DPPC/DOPC/Chol system is classified as a Type II phase-separating316
mixture, which produces macroscopic hemispherical domains [26]. The large317
domains result from high line tension due to a large hydrophobic thickness318
mismatch between the coexisting phases [34, 62, 63]. The linactant theory319
postulates that the addition of molecules that partition preferentially to do-320
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main interfaces should lower the line tension and result in smaller domains.321
This theory has gain more traction recently as Yang et al. showed that αToc322
can minimize line tension at domain boundaries as a means of protecting323
against HIV gp41-mediated membrane fusion [61].324
In the case of αTocQ, the effect on lipid segregation is significantly less325
pronounced. In fact, there is an apparent increase in domain stability with326
even small amounts of αTocQ. Taken together, our results could lead to327
speculation of a physiological benefit for an effective membrane antioxidant.328
Phase boundaries have been identified as a favourable site for membrane329
permeation [64]. As suggested by Yang et al., tocopherol stabilizes domain330
interfaces to produce a less permeable boundary [61]. Considering the theory331
described by Cruzeiro-Hansson and Mouritsen [65] and refined by Cordeiro332
[66], a reduction in bilayer thickness mismatch reduces the possibility of pore333
mediated permeation of oxidants. In the instance of membrane oxidation, the334
initial formation of hydroperoxide lipids promotes the formation of domain335
interfaces [67], which would be stabilized by present tocopherols. As oxida-336
tion progresses, chemistry evolves the stable products α-tocopherylquinone337
and truncated lipids which together drives phase separation [68]. This final338
increase in lipid raft stability is a potential signal to recruit key proteins to339
recover or terminate the cell. In this manner, tocopherol would offer a new340
dimension to its antioxidant activity by protecting the cell membrane from341
oxidation induced lateral organization and permeation.342
Again, we must be cautious in extending these observations into the phys-343
iological realm. The phase modulation we observe arises at vitamin E con-344




In an effort to begin testing a proposed mechanism of vitamin E’s anti-348
cancer action, we reported on the effect that different members of the vitamin349
E family have on lipid domains. Data were collected using two different350
SANS configurations and microscopy, all of which yield consistent results351
with regards to vitamin E’s influence on membrane organization. Though352
its phase behaviour is consistent with its membrane-protective role when in353
concentrations ranging between 0.0001 < χ < 0.004 [11], the lack of lipid354
domain response at χ = 0.02 αToc or γToc strongly suggests that increased355
vitamin E intake does not destabilize domains, as has been proposed. With356
regard to the complexity and variety of phase-active compounds in the native357
membrane, it seems unlikely that a local mole fraction of vitamin E greater358
than 0.02 is a definite actuator of domain stability. Therefore, the present359
work scrutinizes the validity of supplementing vitamin E as a presumed anti-360
cancer agent.361
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[38] J. Pencer, V. N. Anghel, N. Kučerka, J. Katsaras, Scattering from509
laterally heterogeneous vesicles. I. Model-independent analysis, Journal510
of Applied Crystallography 39 (2006) 791–796.511
[39] P. V. Konarev, V. V. Volkov, A. V. Sokolova, M. H. Koch, D. I. Svergun,512
PRIMUS: A Windows PC-based system for small-angle scattering data513
analysis, Journal of Applied Crystallography 36 (2003) 1277–1282.514
[40] G. Pabst, M. Rappolt, H. Amenitsch, P. Laggner, Structural information515
from\nmultilamellar liposomes at full hydration: Full q-range fitting516
with high quality x-ray\ndata, Physical Review E 52 (2000) 4000–4009.517
[41] G. Pabst, J. Katsaras, V. A. Raghunathan, M. Rappolt, Structure and518
interactions in the anomalous swelling regime of phospholipid bilayers,519
Langmuir 19 (2003) 1716–1722.520
[42] T. M. Konyakhina, G. W. Feigenson, Phase diagram of a polyunsatu-521
rated lipid mixture: Brain sphingomyelin/1-stearoyl-2-docosahexaenoyl-522
sn-glycero-3-phosphocholine/cholesterol, Biochimica et Biophysica Acta523
- Biomembranes 1858 (2016) 153–161.524
28
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